Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xu Steven Xu

Showing results (1-10 of 58) with videos related to

Pageof 6
Sort By:
Clinical Pharmacology and Therapeutics|June 5, 2026
Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development RoadmapMin Yuan, Xu Steven Xu
Pharmaceutical Statistics|March 13, 2012
Analysis of dose-response in flexible dose titration clinical studiesXu Steven Xu, Min Yuan, Partha Nandy
Journal of Pharmacokinetics and Pharmacodynamics|April 1, 2011
Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response modelsXu Steven Xu, Hui Wang, An Vermeulen
Expert Opinion on Drug Metabolism & Toxicology|January 17, 2014
Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessmentHaitao Yang, Yan Feng, Xu Steven Xu
The AAPS Journal|August 29, 2014
Modeling of bounded outcome scores with data on the boundaries: application to disability assessment for dementia scores in Alzheimer's diseaseXu Steven Xu, Mahesh Samtani, Min Yuan, et al.
Genetica|September 4, 2021
Fast and efficient correction for population stratification in multi-locus genome-wide association studiesRui Liu, Min Yuan, Xu Steven Xu, et al.
Current Genomics|March 14, 2022
Quantitative Trait Loci Identification by Estimating the Genetic Model based on the Extremal SamplesZining Yang, Yaning Yang, Xu Steven Xu, et al.
JCO Precision Oncology|July 8, 2024
Improving Prediction of Survival and Progression in Metastatic Non-Small Cell Lung Cancer After Immunotherapy Through Machine Learning of Circulating Tumor DNAHaolun Ding, Xu Steven Xu, Yaning Yang, et al.
NPJ Precision Oncology|January 8, 2025
Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Nature Communications|August 10, 2024
Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Pageof 6

Showing results (1-10 of 58) with videos related to

Sort By:
Pageof 6
Clinical Pharmacology and Therapeutics|June 5, 2026
Translating B-Cell and Plasma-Cell Targeting from Oncology to Autoimmunity: Modalities, Quantitative Bridging, and a Development RoadmapMin Yuan, Xu Steven Xu
Pharmaceutical Statistics|March 13, 2012
Analysis of dose-response in flexible dose titration clinical studiesXu Steven Xu, Min Yuan, Partha Nandy
Journal of Pharmacokinetics and Pharmacodynamics|April 1, 2011
Modeling delayed drug effect using discrete-time nonlinear autoregressive models: a connection with indirect response modelsXu Steven Xu, Hui Wang, An Vermeulen
Expert Opinion on Drug Metabolism & Toxicology|January 17, 2014
Pharmacokinetic and pharmacodynamic modeling for acute and chronic pain drug assessmentHaitao Yang, Yan Feng, Xu Steven Xu
The AAPS Journal|August 29, 2014
Modeling of bounded outcome scores with data on the boundaries: application to disability assessment for dementia scores in Alzheimer's diseaseXu Steven Xu, Mahesh Samtani, Min Yuan, et al.
Genetica|September 4, 2021
Fast and efficient correction for population stratification in multi-locus genome-wide association studiesRui Liu, Min Yuan, Xu Steven Xu, et al.
Current Genomics|March 14, 2022
Quantitative Trait Loci Identification by Estimating the Genetic Model based on the Extremal SamplesZining Yang, Yaning Yang, Xu Steven Xu, et al.
JCO Precision Oncology|July 8, 2024
Improving Prediction of Survival and Progression in Metastatic Non-Small Cell Lung Cancer After Immunotherapy Through Machine Learning of Circulating Tumor DNAHaolun Ding, Xu Steven Xu, Yaning Yang, et al.
NPJ Precision Oncology|January 8, 2025
Longitudinal genomic profiling using liquid biopsies in metastatic nonsquamous NSCLC following first line immunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Nature Communications|August 10, 2024
Identifying key circulating tumor DNA parameters for predicting clinical outcomes in metastatic non-squamous non-small cell lung cancer after first-line chemoimmunotherapyHaolun Ding, Min Yuan, Yaning Yang, et al.
Pageof 6